When your job involves trying to bring to market what could be the biggest breakthrough in birth control since the pill, you keep your mornings predictable. Every weekday, Saundra Pelletier gets up at 4:30 a.m., trying not to wake her 10-year-old son while she slips into her workout gear, which includes a sweatshirt with the word bullshit printed on the left shoulder. By 5, the 48-year-old single mom–who lives about a half hour from the San Diego offices of her company, Evofem Biosciences–is on the phone, often with her investors in London. At 5:30, still on the phone, Pelletier exits her garage with a quick nod to the nanny, who is on her way in. Half an hour later, she’s at either CrossFit or Fitwall, where she can work all the major muscle groups in 40 minutes. As the cool-down session begins, Pelletier bolts, already en route to her next stop and a triple soy latte from Starbucks. Since there are no locker rooms at either gym, she swings back home–the phone automatically clicking over to a waterproof speaker in her bathroom–to clean up. Back in her car, she dictates emails to her assistant, until arriving at the office by 8:30. “We get quite a lot done, actually,” she says.
An exercise pill feels like cheating.
It doesn’t seem right that a simple drug should allow you to avoid the crucible of pain, sweating and aggravation that we’ve come to see as the price that must be paid for a fit and low-fat body.
You might be familiar with the concept of 3D-printed medical equipment, but you’re going to have to get used to seeing 3D-printed medicine, too. The US Food and Drug Administration has approved its first drug manufactured using 3D printing, Aprecia’s epilepsy-fighting Spritam.